Letters Advice on homoeopathic products

Authors’ reply to Fisher and 47 colleagues

BMJ 2011; 343 doi: http://dx.doi.org/10.1136/bmj.d6693 (Published 18 October 2011) Cite this as: BMJ 2011;343:d6693
  1. Susan Bewley, obstetric consultant1
  2. On behalf of Edzard Ernst, John Garrow, Nick Ross, Les Rose, Michael Baum, James May, Alain Braillon, David Bender
  1. 1King’s Health Partners, London SE1 7EH, UK
  1. susan.bewley{at}kcl.ac.uk

We rise to the challenge to critically evaluate the five articles mustered in defence of homoeopathy by Fisher and 47 colleagues.1

The meta-analysis by Wiesenauer and Luedtke included eight randomised controlled trials (RCTs).2 A re-analysis of the four published placebo controlled RCTs revealed serious flaws, including non-validated outcome measures, all the studies originating from Wiesenauer’s own group, and a lack of independent replication.3 Furthermore, relatively low dilutions were used, which contain active molecules …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial